Incidence and characterization of neurological adverse events among a retrospective cohort of patients receiving immune checkpoint inhibitors

被引:0
|
作者
Hunting, John
Faucheux, Andrew T.
Elko, Catherine A.
Bloomer, Chance H.
Duckworth, Christopher
Khoury, Lara M.
Strauss, Josh
Olson, Eric
Petty, William J.
Lycan, Thomas William
机构
[1] Wake Forest Baptist Med Ctr, Winston Salem, NC USA
[2] Wake Forest Univ, Sch Med, Winston Salem, NC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2655
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Patterns of neurological adverse events among a retrospective cohort of patients receiving immune checkpoint inhibitors
    Hunting, John C.
    Faucheux, Andrew T.
    Price, Sarah N.
    Elko, Catherine A.
    Quattlebaum, Alexander
    Bloomer, Chance
    Olson, Eric
    Petty, William J.
    Lycan Jr, Thomas W.
    IMMUNOTHERAPY, 2024, 16 (06) : 381 - 390
  • [2] Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study
    Fonseca, Elianet
    Cabrera-Maqueda, Jose M.
    Ruiz-Garcia, Raquel
    Naranjo, Laura
    Diaz-Pedroche, Carmen
    Velasco, Roser
    Macias-Gomez, Adria
    Milisenda, Jose C.
    Munoz-Farjas, Elena
    Pascual-Goni, Elba
    Perez-Larraya, Jaime Gallego
    Saiz, Albert
    Dalmau, Josep
    Blanco, Yolanda
    Graus, Francesc
    Martinez-Hernandez, Eugenia
    LANCET NEUROLOGY, 2023, 22 (12): : 1150 - 1159
  • [3] A Retrospective Cohort Study of Multiple Immune-Related Adverse Events and Clinical Outcomes Among Patients With Cancer Receiving Immune Checkpoint Inhibitors
    Hata, Hiroki
    Matsumura, Chikako
    Chisaki, Yugo
    Nishioka, Kae
    Tokuda, Misaki
    Miyagi, Kazuyo
    Suizu, Tomoki
    Yano, Yoshitaka
    CANCER CONTROL, 2022, 29
  • [4] Cutaneous adverse events to immune checkpoint inhibitors in retrospective cohort study
    McCormack, Lindsay
    Thompson, Leah L.
    Chang, Michael S.
    Polyakov, Nicole
    Song, Hannah
    Chen, Steven T.
    Huang, Jennifer T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (06) : 1587 - 1589
  • [5] Neurological adverse events of immune checkpoint inhibitors - a monocentric prospective cohort study
    Moehn, N.
    Narten, E.
    Duzzi, L.
    Mahjoub, S.
    Graalmann, T.
    Heoglinger, G.
    Kalinke, U.
    Beutel, G.
    Wirth, T.
    Vogel, A.
    Berliner, D.
    Bollmann, B.
    Gutzmer, R.
    Ivanyi, P.
    Grimmelmann, I.
    Skripuletz, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 10 - 10
  • [6] Effects of smoking status on incidence and severity of immunerelated adverse events among patients with melanoma receiving immune checkpoint inhibitors
    Pan, Catherina
    Lau, Charles
    Kim, Daniel
    Lau, William
    Rowley, Rachael
    Kanwar, Ruhi
    LeBoeuf, Nicole
    Nambudiri, Vinod
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB155 - AB155
  • [7] Immune-checkpoint inhibitors and neurological adverse events
    Tummala, Sudhakar
    LANCET NEUROLOGY, 2023, 22 (12): : 1093 - 1094
  • [8] Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study
    Pan, Catherina X.
    Kim, Daniel Y.
    Lau, Charles B.
    Lau, William C.
    Rowley, Rachael
    Kanwar, Ruhi
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (05) : 637 - 640
  • [9] Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study
    Pan, Catherina X.
    Kim, Daniel Y.
    Lau, Charles B.
    Lau, William C.
    Rowley, Rachael
    Kanwar, Ruhi
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    BRITISH JOURNAL OF DERMATOLOGY, 2023,
  • [10] Impact of obesity on the risk of immune-related adverse events (irAEs) among patients receiving immune-checkpoint inhibitors (ICI) treatment: A retrospective cohort study
    Elsaid, Mohamed I.
    Paskett, Electra D.
    Shendre, Aditi
    Manne, Ashish
    Li, Lang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)